Vaxxinity, Inc.
VAXX
$0.0002
-$0.0153-98.71%
OTC PK
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 3.43M | 5.54M | 6.08M | 7.38M | 7.81M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.65M | 13.45M | 14.43M | 18.81M | 20.82M |
| Operating Income | -11.65M | -13.45M | -14.43M | -18.81M | -20.82M |
| Income Before Tax | -11.39M | -13.15M | -13.98M | -18.42M | -20.46M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -11.39M | -13.15M | -13.98M | -18.42M | -20.46M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.39M | -13.15M | -13.98M | -18.42M | -20.46M |
| EBIT | -11.65M | -13.45M | -14.43M | -18.81M | -20.82M |
| EBITDA | -11.19M | -12.78M | -13.90M | -18.22M | -20.28M |
| EPS Basic | -0.09 | -0.10 | -0.11 | -0.15 | -0.16 |
| Normalized Basic EPS | -0.06 | -0.06 | -0.07 | -0.09 | -0.10 |
| EPS Diluted | -0.09 | -0.10 | -0.11 | -0.15 | -0.16 |
| Normalized Diluted EPS | -0.06 | -0.06 | -0.07 | -0.09 | -0.10 |
| Average Basic Shares Outstanding | 127.22M | 126.74M | 126.48M | 126.06M | 126.06M |
| Average Diluted Shares Outstanding | 127.22M | 126.74M | 126.48M | 126.06M | 126.06M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |